15 pitfalls and how to avoid them in clinical reseach

Getting a new drug approved is becoming more difficult. Although the FDA has gotten better at

approving drugs and approving them faster, the regulatory agency is approving fewer new drug

applications. Complicating the process are many snags that could be avoided. There are 15 big

mistakes that companies commonly make in filing a new drug application. Pharmcompanies can avoid these mistakes by paying more attention.